Cargando…

Engineering triiodothyronine (T3) nanoparticle for use in ischemic brain stroke

A potential means of pharmacological management of ischemic stroke is rapid intervention using potent neuroprotective agents. Thyroid hormone (T3) has been shown to protect against ischemic damage in middle cerebral artery occlusion (MCAO) model of ischemic brain stroke. While thyroid hormone is per...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mdzinarishvili, Alexander, Sutariya, Vijaykumar, Talasila, Phani K., Geldenhuys, Werner J., Sadana, Prabodh
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3693440/ https://www.ncbi.nlm.nih.gov/pubmed/23864999 http://dx.doi.org/10.1007/s13346-012-0117-8

Ejemplares similares

CArG-driven GADD45α activated by resveratrol inhibits lung cancer cells
por: Shi, Qiwen, et al.
Publicado: (2015)

Free Triiodothyronine Is Associated with Poor Outcomes after Acute Ischemic Stroke
por: Song, Yue, et al.
Publicado: (2022)

Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult
por: Karakus, Ozlem Ozen, et al.
Publicado: (2021)

Decrease of thyroid function after ischemic stroke is related to stroke severity
por: Sidorov, Evgeny, et al.
Publicado: (2023)

Mitochondria as Key Targets of Cardioprotection in Cardiac Ischemic Disease: Role of Thyroid Hormone Triiodothyronine
por: Forini, Francesca, et al.
Publicado: (2015)

Effect of triiodothyronine on hyperandrogenism in women
por: Kazanavicius, Gintautas, et al.
Publicado: (2013)

Low triiodothyronine syndrome is associated with hemorrhagic transformation in patients with acute ischaemic stroke
por: Huang, Gui-Qian, et al.
Publicado: (2019)

Triiodothyronine modulates neuronal plasticity mechanisms to enhance functional outcome after stroke
por: Talhada, Daniela, et al.
Publicado: (2019)

Diagnostic Values of Free Triiodothyronine and Free Thyroxine and the Ratio of Free Triiodothyronine to Free Thyroxine in Thyrotoxicosis
por: Chen, Xinxin, et al.
Publicado: (2018)

Triiodothyronine Acts as a Smart Influencer on Hsp90 via a Triiodothyronine Binding Site
por: Fan, Lu, et al.
Publicado: (2022)

Triiodothyronine (T(3)) ameliorates the cytokine storm in rats with sepsis
por: Yokoe, T, et al.
Publicado: (2000)

Measurement of Reverse Triiodothyronine Level and the Triiodothyronine to Reverse Triiodothyronine Ratio in Dried Blood Spot Samples at Birth May Facilitate Early Detection of Monocarboxylate Transporter 8 Deficiency
por: Iwayama, Hideyuki, et al.
Publicado: (2021)

Correction: Karakus et al. Development of Triiodothyronine Polymeric Nanoparticles for Targeted Delivery in the Cardioprotection against Ischemic Insult. Biomedicines 2021, 9, 1713
por: Karakus, Ozlem Ozen, et al.
Publicado: (2022)

Molecular Basis for the Remarkably Different Gas-Phase Behavior of Deprotonated Thyroid Hormones Triiodothyronine (T3) and Reverse Triiodothyronine (rT3): A Clue for Their Discrimination?
por: Corinti, Davide, et al.
Publicado: (2021)

Ischemic Stroke in Confederation with Trivial Head Trauma
por: Balachandran, Archana, et al.
Publicado: (2016)

Rewiring of liver diurnal transcriptome rhythms by triiodothyronine (T(3)) supplementation
por: de Assis, Leonardo Vinicius Monteiro, et al.
Publicado: (2022)

Free Triiodothyronine and Free Triiodothyronine to Free Thyroxine Ratio Predict All-Cause Mortality in Patients with Diabetic Foot Ulcers
por: Hong, Jing, et al.
Publicado: (2022)

Remuscularization with triiodothyronine and β(1)-blocker therapy reverses post-ischemic left ventricular dysfunction and adverse remodeling
por: Bogush, Nikolay, et al.
Publicado: (2022)

Triiodothyronine modulates the expression of leptin and adiponectin in 3T3-L1 adipocytes
por: de Oliveira, Miriane, et al.
Publicado: (2015)

Low Levels of Triiodothyronine in Patients with Alzheimer’s Disease
por: Karimi, Fariba, et al.
Publicado: (2011)

Free Triiodothyronine Concentrations Are Inversely Associated with Microalbuminuria
por: Zhou, Yulin, et al.
Publicado: (2014)

The correlation between triiodothyronine and the severity of liver fibrosis
por: He, Weiwei, et al.
Publicado: (2022)

Factitious Total Triiodothyronine(T3) Elevation in a Euthyroid Patient With Paraproteinemia
por: Mandal, Kaushik, et al.
Publicado: (2021)

Triiodothyronine (T3), inflammation and mortality risk in patients with acute myocardial infarction
por: Razvi, Salman, et al.
Publicado: (2022)

Regulation of Thyroid Hormone-, Oestrogen- and Androgen-Related Genes by Triiodothyronine in the Brain of Silurana tropicalis
por: Duarte-Guterman, Paula, et al.
Publicado: (2010)

Sequential activation of Elk-1/Egr-1/GADD45α by arsenic
por: Shi, Qiwen, et al.
Publicado: (2014)

Biomimetic nanoparticles in ischemic stroke therapy
por: Liu, Zihao, et al.
Publicado: (2023)

Engineered extracellular vesicles for ischemic stroke treatment
por: Ruan, Huitong, et al.
Publicado: (2023)

Triiodothyronine (T3) Induces Limited Transcriptional and DNA Methylation Reprogramming in Human Monocytes
por: Shepherd, Rebecca, et al.
Publicado: (2022)

Serum triiodothyronine levels and inflammatory cytokine production capacity
por: Rozing, Maarten P., et al.
Publicado: (2011)

Low triiodothyronine predicts mortality in critically ill patients
por: Kumar, K. V. S. Hari, et al.
Publicado: (2013)

Prognostic value of free triiodothyronine in patients with dilated cardiomyopathy
por: Zhao, Hong-Yan, et al.
Publicado: (2020)

Incidence of low-triiodothyronine syndrome in patients with septic shock
por: Cornu, Matias German, et al.
Publicado: (2020)

High free triiodothyronine, and free-triiodothyronine-to-free-thyroxine ratio are associated with metabolic syndrome in a euthyroid employee population: the Zhejiang Zhenhai study
por: Jin, Qiankai, et al.
Publicado: (2023)

Early Pro-Inflammatory Remodeling of HDL Proteome in a Model of Diet-Induced Obesity: (2)H(2)O-Metabolic Labeling-Based Kinetic Approach
por: Sadana, Prabodh, et al.
Publicado: (2020)

GADD45α-targeted suicide gene therapy driven by synthetic CArG promoter E9NS sensitizes NSCLC cells to cisplatin, resveratrol, and radiation regardless of p53 status
por: Shi, Qiwen, et al.
Publicado: (2019)

L-3,3’,5-triiodothyronine and pregnenolone sulfate inhibit Torpedo nicotinic acetylcholine receptors
por: Moffett, Steven X., et al.
Publicado: (2019)

3,5,3′-Triiodothyronine–Loaded Liposomes Inhibit Hepatocarcinogenesis Via Inflammation-Associated Macrophages
por: Sun, Gangqi, et al.
Publicado: (2022)

Effects of triiodothyronine replacement therapy in patients with chronic stable heart failure and low‐triiodothyronine syndrome: a randomized, double‐blind, placebo‐controlled study
por: Amin, Ahmad, et al.
Publicado: (2015)

Therapeutic Nanoparticles for the Different Phases of Ischemic Stroke
por: Bernardo-Castro, Sara, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ufsi0ssqidkuh6sko9jfnv0mji